ORIX Corporation filed a report summarizing the voting results from its 63rd Annual General Meeting of Shareholders held on June 23, 2026. Shareholders approved amendments to the Articles of Incorporation clarifying the company’s business purposes and enabling virtual-only shareholders’ meetings, with approval rates of 99.87% and 77.23%, respectively. Ten directors were elected or re-elected, including new directors Shuji Irie, Masataka Yamada, and Akiko Hosokawa, each receiving around 99% approval. The filing was made as an extraordinary report to the Kanto Financial Bureau in accordance with Japanese disclosure regulations.
ORIX CORP director Kato Mami reported a restructuring of share-based compensation awards held through a trust. The Form 4 shows 2,000 "Share-based Compensation Points" as a derivative entry, each point representing the right to receive one share of Common Stock upon retirement under ORIX Corporation's share-based compensation program. After this transaction, 4,000 such points are shown as held indirectly through a Board Incentive Plan Trust. This is a compensation-related derivative reporting entry rather than an open-market stock purchase or sale.
ORIX Corporation filed a Form 6-K outlining updated Articles of Incorporation, leadership changes and new performance share grants. The Articles, last amended on June 23, 2026, confirm 2,590,000,000 authorized shares and a unit share system of 100 shares per voting unit.
ORIX promoted Satoru Matsuzaki to Representative Executive Officer, Deputy President and Chief Operating Officer of the Japan & APAC Business Unit, while Executive Officer Hao Li will retire and the Greater China Group will be folded into the Asia-Pacific Business Headquarters. The company also approved performance share units under its performance-linked share-based compensation plan, including Unit 1 for 6,300 shares and Unit 2 for 9,500 shares, and separately describes Unit 1 for 35,200 shares and Unit 2 for 53,000 shares for executive officers, all linked to ROE, relative TSR and tenure-based metrics.
ORIX Corporation reported progress on its ongoing share repurchase program. Between May 22 and May 31, 2026, the company bought back 1,693,600 common shares for a total of JPY 10,574,598,800 through market purchases under a discretionary dealing contract.
This buyback is part of a larger Board-authorized program, allowing repurchases of up to 100,000,000 common shares, or approximately 9.1% of outstanding shares excluding treasury stock, for up to JPY 250 billion. The program runs from May 22, 2026 to March 31, 2027, signaling a sizable capital return framework while leaving substantial capacity for additional repurchases.
ORIX Corporation reports that gains recognized by Toshiba Corporation on sales and valuation of shares in Kioxia Holdings, through TB Investment Limited Partnership, are expected to materially lift its upcoming quarterly results. ORIX estimates equity in net income of equity method investments of approximately ¥179.8 billion (before tax) will be recorded in the first quarter of the fiscal year ending March 31, 2027. The additional impact on Net Income Attributable to ORIX Corporation Shareholders for that quarter is estimated at an increase of approximately ¥70.0 billion, on top of a previously announced full-year net income forecast of ¥530.0 billion. ORIX cautions that the full-year impact for the fiscal year ending March 31, 2027 cannot be reasonably determined yet and will depend on Toshiba’s future financial results, Toshiba’s transactions in Kioxia shares and future Kioxia share prices.
ORIX Corporation expects Toshiba Corporation’s latest results to affect its earnings for the first quarter of the fiscal year ending March 31, 2027. Toshiba’s full-year results for the year ended March 31, 2026 include income related to Kioxia Holdings Corporation of ¥2,277 billion.
ORIX indirectly owns part of Toshiba through TB Investment Limited Partnership, an equity‑method affiliate, so the partnership’s fourth‑quarter results and the Kioxia‑related income are expected to flow into ORIX’s consolidated first‑quarter figures. The impact on full‑year Net Income Attributable to ORIX Shareholders for the year ending March 31, 2027 is still under detailed review, and ORIX plans to announce more once the gain on the sale of securities and valuation gain become reasonably estimable.